Processing

Please wait...

Settings

Settings

Goto Application

1. WO2002022830 - TRANSGLUTAMINASE GENE PRODUCTS

Publication Number WO/2002/022830
Publication Date 21.03.2002
International Application No. PCT/GB2001/004120
International Filing Date 14.09.2001
Chapter 2 Demand Filed 10.04.2002
IPC
A61K 48/00 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
48Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
C12N 9/10 2006.01
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
9Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes
10Transferases (2.)
G01N 33/564 2006.01
GPHYSICS
01MEASURING; TESTING
NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
33Investigating or analysing materials by specific methods not covered by groups G01N1/-G01N31/131
48Biological material, e.g. blood, urine; Haemocytometers
50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
53Immunoassay; Biospecific binding assay; Materials therefor
564for pre-existing immune complex or autoimmune disease
G01N 33/573 2006.01
GPHYSICS
01MEASURING; TESTING
NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
33Investigating or analysing materials by specific methods not covered by groups G01N1/-G01N31/131
48Biological material, e.g. blood, urine; Haemocytometers
50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
53Immunoassay; Biospecific binding assay; Materials therefor
573for enzymes or isoenzymes
CPC
A61K 48/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
48Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
C12N 9/1044
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
9Enzymes; Proenzymes; Compositions thereof
10Transferases (2.)
1025Acyltransferases (2.3)
104Aminoacyltransferases (2.3.2)
1044Protein-glutamine gamma-glutamyltransferase (2.3.2.13), i.e. transglutaminase or factor XIII
G01N 33/564
GPHYSICS
01MEASURING; TESTING
NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
33Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
48Biological material, e.g. blood, urine
50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
53Immunoassay; Biospecific binding assay; Materials therefor
564for pre-existing immune complex or autoimmune disease ; , i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
G01N 33/573
GPHYSICS
01MEASURING; TESTING
NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
33Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
48Biological material, e.g. blood, urine
50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
53Immunoassay; Biospecific binding assay; Materials therefor
573for enzymes or isoenzymes
Applicants
  • UNIVERSITY COLLEGE CARDIFF CONSULTANTS LTD. [GB]/[GB] (AllExceptUS)
  • AESCHLIMANN, Daniel, Peter [CH]/[GB] (UsOnly)
  • GRENARD, Pascale, Marie [FR]/[GB] (UsOnly)
Inventors
  • AESCHLIMANN, Daniel, Peter
  • GRENARD, Pascale, Marie
Agents
  • TOMBLING, Adrian, George
Priority Data
0022768.615.09.2000GB
0111995.716.05.2001GB
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) TRANSGLUTAMINASE GENE PRODUCTS
(FR) PRODUITS GENIQUES DE TRANSGLUTAMINASE
Abstract
(EN)
The invention provides a nucleotide sequence comprising at least a portion of the nucleotide sequence of Fig. 10A, Fig. 6B or Fig. 10A or Fig. 10B; nucleotides which hybridise to the nucleotide sequences of Fig. 6A, Fig. 6B or Fig. 10A or Fig. 10B; nucleotides which are degenerate to the nucleotide sequences of Fig. 6A, Fig. 6B or Fig. 10A or Fig. 10B; all of which nucleotides encode a polypeptide having transglutaminase activity.
(FR)
La présente invention concerne une séquence nucléotidique comprenant au moins une portion des séquences nucléotidiques décrites dans les figures 6A, 6B, 10A ou 10B; des nucléotides s'hybridant avec les séquences nucléotidiques décrites dans les figures 6A, 6B, 10A ou 10B; des nucléotides dégénérés provenant des séquences nucléotidiques décrites dans les figures 6A, 6B, 10A ou 10B; tous ces nucléotides codant pour un polypeptide présentant une activité transglutaminase.
Latest bibliographic data on file with the International Bureau